Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market
The Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market size was valued at US$ 75.3 Mn in 2021 and is projected to reach US$ 131.3 Mn by 2028, growing at a CAGR of 8.3% during 2021 - 2028.
Report Coverage
- Technology: CTC Detection and Enrichment Method, CTC Direct Detection Method, CTC Analysis
- Application: Clinical/Liquid Biopsy, Research
- End-User: Hospitals and Clinics, Research and Academic Institutes, Diagnostic Centers
US$ 75.3 Mn
Market size in 2021
US$ 131.3 Mn
Market Size by 2028
8.3%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Regional Analysis
6.2 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Forecast Analysis
7. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Technology
7.1 CTC Detection and Enrichment Method
- 7.1.1 Overview
- 7.1.2 CTC Detection and Enrichment Method: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 CTC Direct Detection Method
- 7.2.1 Overview
- 7.2.2 CTC Direct Detection Method: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 CTC Analysis
- 7.3.1 Overview
- 7.3.2 CTC Analysis: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Application
8.1 Clinical/Liquid Biopsy
- 8.1.1 Overview
- 8.1.2 Clinical/Liquid Biopsy: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Research
- 8.2.1 Overview
- 8.2.2 Research: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by End-User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Research and Academic Institutes
- 9.2.1 Overview
- 9.2.2 Research and Academic Institutes: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Diagnostic Centers : Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 South Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.2.1.1.2 South Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
- 10.2.1.2 Saudi Arabia: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
- 10.2.1.3 UAE: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.2.1.3.2 UAE: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
- 10.2.1.4 Rest of Middle East and Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Stemcell Technologies Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Qiagen
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Fluxion Biosciences
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
